Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
---|---|---|---|
USD 22.14 Billion | USD 101.37 Billion | 16.43% | 2024 |
The global CBD consumer health market size was worth around USD 22.14 Billion in 2024 and is predicted to grow to around USD 101.37 Billion by 2034 with a compound annual growth rate (CAGR) of roughly 16.43% between 2025 and 2034. The report analyzes the global CBD consumer health market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the CBD consumer health industry.
Cannabidiol has grown in popularity in nutritional supplements due to its potential health advantages and non-narcotic properties. Unlike THC, it lets users benefit from the health benefits of cannabis without becoming drunk. CBD supplements are perceived as more natural than prescription or over-the-counter drugs for treating stiffness, pain, anxiety, stress, and other medical conditions.
Hemp-derived CBD is a preferred supplier among producers due to its low THC concentration. Cannabidiol is the most recent consumer craze. The expanding number of benefits of cannabidiol in various health applications and marketing & advertising operations by market participants are some of the key forces driving product demand.
The increased availability of consumer product options, such as topicals, analgesics, edibles, oils, tinctures, and a variety of other goods, is also propelling the CBD consumer in the health sector. Furthermore, as people become more aware of the health benefits of CBD-infused products, the number of people ready to purchase them, regardless of price, has grown. Mainstream retailers who previously supplied non-CBD products are increasingly focusing on supplying CBD-based products due to higher profit margins and greater demand. However, the availability of alternatives and the high cost of CBD products are limiting the market growth.
Increasing government approvals for CBD products are likely to pave the way for global market growth
Growing approvals for CBD products are a result of the quick development of treatments, medications, and other consumer goods derived from cannabis and its advantageous health effects. The Food and Drug Administration (FDA) of the United States has acknowledged several possible uses for CBD and the possibility of incorporating it into various food and non-food applications. As a result, the producers are putting more effort into finding CBD to add to food and other items. Thus, during the projection period, the expansion of the global CBD business would benefit from the increasing dependence on products.
Additional barriers in terms of marketing CBD products may hamper the global market growth
Consumers in industrialized nations like the United States, Canada, the United Kingdom, Russia, and others are becoming increasingly fond of CBD-based goods, but not in emerging nations like Asia and the Middle East. The misconception that the product produces psychoactive effects as a result of its popularity among customers for recreational uses hinders its performance on the market. In addition, the features, services, and offerings that are advantageous in numerous ways are not generally known to the consumers.
The abundant utility of CBD in the pharmaceutical sector brings up several growth opportunities
Globally, the constantly expanding pharmaceutical business is aware of the value and advantages of cannabis and its byproducts. One of the main components of cannabis that the pharmaceutical business has used to provide health safety assurance for various illnesses is CBD. It has qualities like being naturally plant-based and a natural substitute for several conventional medicines that are aggressively sold to producers and customers globally.
The presence of alternative plant-based products is likely to limit the global market growth
Due to the availability of substitute plant-based nutraceuticals, including Echinacea, garcinia cambogia, turmeric, and raspberry ketones, and the usage of CBD is illegal in some countries and subject to stringent regulations, the consumer health market for CBD has been hindered.
The global CBD consumer health market is segmented based on Product, Distribution Channel, and region.
Based on Product, the global CBD consumer health market is divided into Medical OTC Products (Analgesics, Dermatology, Mental Health, Sleeping Aids, Others), Nutraceuticals (CBD Vitamins and Dietary Supplements, CBD Sports Nutrition, CBD Weight Management and Wellbeing).
On the basis of Distribution Channel, the global CBD consumer health market is bifurcated into Online Stores, Retail Pharmacies, Retail Stores.
Report Attributes | Report Details |
---|---|
Report Name | CBD Consumer Health Market |
Market Size in 2024 | USD 22.14 Billion |
Market Forecast in 2034 | USD 101.37 Billion |
Growth Rate | CAGR of 16.43% |
Number of Pages | 256 |
Key Companies Covered | Elixinol, ENDOCA, NuLeaf Naturals, Kazmira, Charlotte's Web, Joy Organics, The Cronos Group, Medical Marijuana Inc., CV Sciences, Isodiol International, and others. |
Segments Covered | By Product, By Distribution Channel, and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, The Middle East and Africa (MEA) |
Base Year | 2024 |
Historical Year | 2020 to 2023 |
Forecast Year | 2025 - 2034 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
A higher number of CBD firms is likely to help North America dominate the global market
North America is expected to dominate the global CBD consumer health market during the forecast period. This is due to a higher number of CBD firms and more flexible rules regulating the use of the products.
Furthermore, an increase in consumption, increased awareness of their health benefits, expanding acceptance of CBD-based food & health products, legalizing hemp farming, and production of hemp-derived products in the United States are some of the primary reasons driving demand in North America.
Consumer demographics keep evolving radially, and the utility of CBD has become popular among various manufacturers, including food, pharmaceutical, and cosmetics. The rising demand among various age groups and genders is likely to drive their expenditure on goods.
Over the forecast period, the Asia Pacific regional market is expected to grow significantly in the CBD Consumer Health market. The growing legality and acceptance of cannabidiol for usage in a variety of goods provide various producers with significant market prospects.
Manufacturers' capitalization on customer awareness and product marketing are some of the primary drivers driving market expansion. The region's cannabis sector is expanding due to customers' shifting perspectives since there is more to cannabis than just getting high.
The report provides a company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market, including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the CBD consumer health market on a global and regional basis.
The global CBD consumer health market is dominated by players like:
The global CBD consumer health market is segmented as follows;
By Product
By Distribution Channel
By Region
FrequentlyAsked Questions
Cannabidiol has grown in popularity in nutritional supplements due to its potential health advantages and non-narcotic properties.
The global CBD consumer health market is expected to grow due to increasing legalization, consumer interest in natural wellness products, and rising demand for stress and pain relief solutions.
According to a study, the global CBD consumer health market size was worth around USD 22.14 Billion in 2024 and is expected to reach USD 101.37 Billion by 2034.
The global CBD consumer health market is expected to grow at a CAGR of 16.43% during the forecast period.
North America is expected to dominate the CBD consumer health market over the forecast period.
Leading players in the global CBD consumer health market include Elixinol, ENDOCA, NuLeaf Naturals, Kazmira, Charlotte's Web, Joy Organics, The Cronos Group, Medical Marijuana Inc., CV Sciences, Isodiol International, among others.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed